Jessica AB van Nies
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jessica AB van Nies has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Zuzana de Jong
Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
2 shared publications - Albert Jja Scherpbier
Institute for Education, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands
1 shared publication - Annette H M van der Helm-Van Mil
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication - Fina As Kurreeman
Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
1 shared publication - Friedo Wilhelm Dekker
Department of Clinical Epidemiology, Leiden University Medical Center , Leiden
1 shared publication - Johan Wouter Jukema
Department of Cardiology Leiden University Medical Center Leiden The Netherlands
1 shared publication
Latest Publications
- Open Access
- 13 November 2010
- Published by Springer Nature in BMC Medical Education
- Vol. 10 (1) , 79
Interactive seminars or small group tutorials in preclinical medical education: results of a randomized controlled trial
Learning in small group tutorials is appreciated by students and effective in the acquisition of clinical problem-solving skills but poses financial and resource challenges. Interactive seminars, which accommodate large groups, might be an alternative. This study examines the educational effectiveness of small group tutorials and interactive seminars and students' preferences for and satisfaction with these formats.
- 13 November 2010
- Published by Springer Nature in BMC Medical Education
- Vol. 10 (1) , 79
Open AccessInteractive seminars or small group tutorials in preclinical medical education: results of a randomized controlled trial
Learning in small group tutorials is appreciated by students and effective in the acquisition of clinical problem-solving skills but poses financial and resource challenges. Interactive seminars, which accommodate large groups, might be an alternative. This study examines the educational effectiveness of small group tutorials and interactive seminars and students' preferences for and satisfaction with these formats.
- Open Access
- 5 March 2010
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 12 (2) , R38
TRAF1/C5polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies
Introduction: Recently an association between a genetic variation in TRAF1/C5 and mortality from sepsis or cancer was found in rheumatoid arthritis (RA). The most prevalent cause of death, cardiovascular disease, may have been missed in that study, since patients were enrolled at an advanced disease stage. Therefore, we used an inception cohort of RA patients to investigate the association between TRAF1/C5 and cardiovascular mortality, and replicate the findings on all-cause mortality. As TRAF1/C5 associated mortality may not be restricted to RA, we also studied a large cohort of non-RA patients. Methods: 615 RA patients from the Leiden Early Arthritis Clinic (EAC) (mean follow-up 7.6 years) were genotyped for rs10818488. In addition 5634 persons enrolled in the PROspective Study of Pravastatin in the Elderly at Risk (mean follow-up 3.2 years) were genotyped for rs2416808 (R2 >0.99 with rs10818488). The life/death status was determined and for the deceased persons the cause of death was ascertained. Cox proportional hazards and regression models were used to assess hazard ratios (HR) and 95% confidence intervals (CI). Results: Seventy-seven RA patients died. The main death causes in RA patients were cardiovascular diseases (37.7%), cancer (28.6%) and death due to infections (9.1%). No association was observed between the rs10818488 susceptible genotype AA and cardiovascular mortality (HR 1.08 95%CI 0.54 to 2.15) and all-cause mortality (HR 0.81 95%CI 0.27 to 2.43). Similar findings were observed for rs2416808 susceptible genotype GG in the non-RA cohort (HR 0.99; 95%CI 0.79 to 1.25 and HR 0.89; 95%CI 0.64 to 1.25, respectively). Conclusions: The TRAF1/C5 region is not associated with an increased mortality risk.
- 5 March 2010
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 12 (2) , R38
Open AccessTRAF1/C5polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies
Introduction: Recently an association between a genetic variation in TRAF1/C5 and mortality from sepsis or cancer was found in rheumatoid arthritis (RA). The most prevalent cause of death, cardiovascular disease, may have been missed in that study, since patients were enrolled at an advanced disease stage. Therefore, we used an inception cohort of RA patients to investigate the association between TRAF1/C5 and cardiovascular mortality, and replicate the findings on all-cause mortality. As TRAF1/C5 associated mortality may not be restricted to RA, we also studied a large cohort of non-RA patients. Methods: 615 RA patients from the Leiden Early Arthritis Clinic (EAC) (mean follow-up 7.6 years) were genotyped for rs10818488. In addition 5634 persons enrolled in the PROspective Study of Pravastatin in the Elderly at Risk (mean follow-up 3.2 years) were genotyped for rs2416808 (R2 >0.99 with rs10818488). The life/death status was determined and for the deceased persons the cause of death was ascertained. Cox proportional hazards and regression models were used to assess hazard ratios (HR) and 95% confidence intervals (CI). Results: Seventy-seven RA patients died. The main death causes in RA patients were cardiovascular diseases (37.7%), cancer (28.6%) and death due to infections (9.1%). No association was observed between the rs10818488 susceptible genotype AA and cardiovascular mortality (HR 1.08 95%CI 0.54 to 2.15) and all-cause mortality (HR 0.81 95%CI 0.27 to 2.43). Similar findings were observed for rs2416808 susceptible genotype GG in the non-RA cohort (HR 0.99; 95%CI 0.79 to 1.25 and HR 0.89; 95%CI 0.64 to 1.25, respectively). Conclusions: The TRAF1/C5 region is not associated with an increased mortality risk.